01—Abstract
Summary
Summary of the 8-K filed February 8, 2024. Cited figures are marked; the original filing is the authoritative source.
TransDigm Group (TDG) reported fiscal Q1 2024 results (quarter ended December 30, 2023) that beat expectations and prompted a raise to its fiscal 2024 net sales and EBITDA As Defined guidance.
Net sales rose 28.1% year over year to $1,789 milliona, net income climbed 66.8% to $382 million, and EBITDA As Defined grew 30.5% to $912 million, with the margin expanding about 100 basis points to 51.0%. Organic sales growth was 23.5%, and management attributed the strength to commercial aftermarket expansion and its value-driven operating strategy. Excluding Calspan (acquired May 2023), the EBITDA As Defined margin was approximately 51.8%.
Fiscal 2024 guidance was raised for net sales (midpoint up $85 million to $7,575b-$7,755 million) and EBITDA As Defined (midpoint up $45 million to $3,920-$4,050 million, implying a roughly 52.0% margin). GAAP net income guidance midpoint was lowered $86 million and GAAP EPS midpoint was lowered $1.45, reflecting roughly the incremental interest expense from new debt raised to fund the pending acquisition of CPI's Electron Device Business for about $1.385 billion in cash. The guidance excludes any contribution from that deal, which is expected to close in fiscal 2024 subject to U.S. and U.K. regulatory approvals.
Investors should note the GAAP EPS impact of $1.75c per share from dividend equivalent payments tied to the $35.00 per share special dividend paid in the quarter, which depresses reported EPS while adjusted EPS of $7.16 (up 56%) excludes it. Leverage rose sharply: long-term debt increased to $21.3 billion from $19.3 billion at fiscal year-end, and total stockholders' deficit widened to $(3.5) billion from $(2.0) billion, driven largely by the special dividend. Cash balances rose to $4.1 billion, reflecting the pre-funding of the CPI acquisition.
02—Key points
Key Highlights
- Net sales of $1,789 million, up 28.1% year over year, with organic growth of 23.5%.
- EBITDA As Defined of $912 million, up 30.5%, with margin of 51.0% (up about 100 bps; ~51.8% excluding Calspan).
- GAAP net income of $382 million (up 66.8%) and GAAP EPS of $4.87 (up 46%), reduced by $1.75 per share of dividend equivalent payments; adjusted EPS of $7.16 (up 56%).
- Fiscal 2024 net sales and EBITDA As Defined guidance raised at the midpoint by $85 million and $45 million, respectively; adjusted EPS guidance midpoint lowered $1.12 due to higher interest expense.
- Pending $1.385 billion acquisition of CPI's Electron Device Business, funded by a $1.0 billion 7.125% senior secured notes offering due 2031 and $1.0 billion of Tranche J term loans (SOFR + 3.25%); guidance excludes its contribution.
- Balance sheet leverage increased: long-term debt rose to $21.3 billion and the stockholders' deficit widened to $(3.5) billion, largely from the $35.00 special dividend.
- Management guided to commercial OEM revenue growth of around 20%, commercial aftermarket growth in the mid-teens, and defense growth in the high-single to low-double digits for fiscal 2024.
03—Questions
Frequently Asked Questions
Why did TransDigm raise sales and EBITDA guidance but lower net income and EPS guidance?
The sales and EBITDA As Defined raises reflect strong first-quarter operating results and improved expectations for the rest of the year. Net income and GAAP EPS guidance were lowered because of incremental interest expense from the $2.0 billion of new debt issued in November 2023 to fund the pending CPI Electron Device Business acquisition. Adjusted EPS guidance midpoint was also reduced by $1.12, to $29.97-$31.73 per share.
Why is GAAP EPS so much lower than adjusted EPS this quarter?
GAAP EPS of $4.87 is reduced by $1.75 per share for dividend equivalent payments made to option holders in connection with the $35.00 per share special dividend, plus non-cash stock and deferred compensation expense and other adjustments. Adjusted EPS of $7.16 adds back these items, so it better reflects operating performance on a comparable basis, though investors should weigh the dividend's real cost and the non-GAAP nature of the measure.
What does the pending CPI Electron Device Business acquisition mean for TransDigm?
TransDigm agreed in November 2023 to buy the business for about $1.385 billion in cash, subject to U.S. and U.K. regulatory approvals, with closing expected this fiscal year. The business makes highly engineered aerospace and defense electronic components with significant aftermarket content. Current guidance excludes its EBITDA contribution, so the deal would be additive to fiscal 2024 results if completed, while adding to leverage.
How much leverage and balance sheet risk has TransDigm taken on?
Long-term debt rose to $21.3 billion from $19.3 billion at September 30, 2023, and the total stockholders' deficit grew to $(3.5) billion from $(2.0) billion, largely due to the special dividend. Cash increased to $4.1 billion, partly reflecting pre-funding of the acquisition. TransDigm's EBITDA As Defined margin of about 51% and strong cash generation (operating cash flow of $636 million in the quarter) support debt service, but the company's high leverage remains a key risk factor for investors.
What drove the strong first-quarter growth?
Management attributed growth to expanding commercial aftermarket revenues and the company's value-driven operating strategy, which supported pricing and cost control. Organic sales growth was 23.5%, and the Calspan acquisition, completed in May 2023, contributed to reported growth, though the margin excluding Calspan was still about 51.8%. Fiscal 2024 guidance assumes commercial OEM growth of around 20%, commercial aftermarket growth in the mid-teens, and defense growth in the high-single to low-double digits.
04—Continue